Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_C3,10 | Lung | Primary cancer | 4,126 | Tumor/Malignant | 38.2% | 0.97 | 0.15 |
| NSCLC_38242124__IMC__175_C3,11 | Lung | Primary cancer | 3,559 | Tumor/Malignant | 37.8% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_C3,12 | Lung | Primary cancer | 5,911 | Stromal | 71.6% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__175_C3,13 | Lung | Primary cancer | 4,207 | Stromal | 60.4% | 0.94 | 0.16 |
| NSCLC_38242124__IMC__175_C3,14 | Lung | Primary cancer | 3,826 | Stromal | 61.8% | 0.91 | 0.25 |
| NSCLC_38242124__IMC__175_C3,15 | Lung | Primary cancer | 283 | Stromal | 58.0% | 0.85 | 0.37 |
| NSCLC_38242124__IMC__175_C3,16 | Lung | Primary cancer | 5,848 | Immune | 61.0% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_C3,2 | Lung | Primary cancer | 2,343 | Tumor/Malignant | 34.0% | 0.67 | 0.62 |
| NSCLC_38242124__IMC__175_C3,3 | Lung | Primary cancer | 3,110 | Stromal | 22.5% | 0.81 | 0.46 |
| NSCLC_38242124__IMC__175_C3,4 | Lung | Primary cancer | 3,721 | Tumor/Malignant | 47.8% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__175_C3,5 | Lung | Primary cancer | 2,899 | Tumor/Malignant | 45.2% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__175_C3,6 | Lung | Primary cancer | 2,613 | Stromal | 30.5% | 0.59 | 0.79 |
| NSCLC_38242124__IMC__175_C3,7 | Lung | Primary cancer | 3,382 | Tumor/Malignant | 45.0% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__175_C3,8 | Lung | Primary cancer | 2,698 | Tumor/Malignant | 62.9% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__175_C3,9 | Lung | Primary cancer | 2,511 | Tumor/Malignant | 47.1% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__175_C4,1 | Lung | Primary cancer | 1,967 | Tumor/Malignant | 62.4% | 0.96 | 0.14 |
| NSCLC_38242124__IMC__175_C4,10 | Lung | Primary cancer | 3,736 | Tumor/Malignant | 50.4% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__175_C4,11 | Lung | Primary cancer | 3,999 | Tumor/Malignant | 37.4% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__175_C4,12 | Lung | Primary cancer | 5,572 | Stromal | 79.9% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__175_C4,13 | Lung | Primary cancer | 4,073 | Stromal | 75.2% | 0.98 | 0.07 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_C3,10 | Lung | Primary cancer | 4,126 | Tumor/Malignant | 38.9% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_C3,11 | Lung | Primary cancer | 3,559 | Tumor/Malignant | 40.4% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__175_C3,12 | Lung | Primary cancer | 5,911 | Stromal | 53.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_C3,13 | Lung | Primary cancer | 4,207 | Stromal | 60.6% | 0.94 | 0.17 |
| NSCLC_38242124__IMC__175_C3,14 | Lung | Primary cancer | 3,826 | Stromal | 35.7% | 0.78 | 0.46 |
| NSCLC_38242124__IMC__175_C3,15 | Lung | Primary cancer | 283 | Stromal | 58.7% | 0.84 | 0.37 |
| NSCLC_38242124__IMC__175_C3,16 | Lung | Primary cancer | 5,848 | Lymphoid | 46.5% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__175_C3,2 | Lung | Primary cancer | 2,343 | Tumor/Malignant | 31.2% | 0.69 | 0.59 |
| NSCLC_38242124__IMC__175_C3,3 | Lung | Primary cancer | 3,110 | Stromal | 26.5% | 0.35 | 1.09 |
| NSCLC_38242124__IMC__175_C3,4 | Lung | Primary cancer | 3,721 | Tumor/Malignant | 34.9% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__175_C3,5 | Lung | Primary cancer | 2,899 | Stromal | 26.6% | 0.80 | 0.49 |
| NSCLC_38242124__IMC__175_C3,6 | Lung | Primary cancer | 2,613 | Stromal | 30.8% | 0.86 | 0.41 |
| NSCLC_38242124__IMC__175_C3,7 | Lung | Primary cancer | 3,382 | Tumor/Malignant | 37.8% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_C3,8 | Lung | Primary cancer | 2,698 | Tumor/Malignant | 46.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_C3,9 | Lung | Primary cancer | 2,511 | Tumor/Malignant | 47.3% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__175_C4,1 | Lung | Primary cancer | 1,967 | Tumor/Malignant | 50.5% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__175_C4,10 | Lung | Primary cancer | 3,736 | Tumor/Malignant | 62.5% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__175_C4,11 | Lung | Primary cancer | 3,999 | Tumor/Malignant | 36.2% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__175_C4,12 | Lung | Primary cancer | 5,572 | Stromal | 78.6% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_C4,13 | Lung | Primary cancer | 4,073 | Stromal | 67.7% | 0.99 | 0.03 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_C3,10 | Lung | Primary cancer | 4,126 | Tumor/Malignant cell | 44.3% | 0.94 | 0.25 |
| NSCLC_38242124__IMC__175_C3,11 | Lung | Primary cancer | 3,559 | Tumor/Malignant cell | 51.8% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__175_C3,12 | Lung | Primary cancer | 5,911 | Fibroblast | 70.5% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__175_C3,13 | Lung | Primary cancer | 4,207 | Fibroblast | 61.6% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__175_C3,14 | Lung | Primary cancer | 3,826 | Fibroblast | 62.8% | 0.90 | 0.26 |
| NSCLC_38242124__IMC__175_C3,15 | Lung | Primary cancer | 283 | Fibroblast | 67.1% | 0.79 | 0.49 |
| NSCLC_38242124__IMC__175_C3,16 | Lung | Primary cancer | 5,848 | T cell | 59.6% | 0.76 | 0.46 |
| NSCLC_38242124__IMC__175_C3,2 | Lung | Primary cancer | 2,343 | Tumor/Malignant cell | 31.3% | 0.69 | 0.59 |
| NSCLC_38242124__IMC__175_C3,3 | Lung | Primary cancer | 3,110 | Endothelial cell | 21.0% | 0.30 | 1.19 |
| NSCLC_38242124__IMC__175_C3,4 | Lung | Primary cancer | 3,721 | Tumor/Malignant cell | 53.9% | 0.90 | 0.33 |
| NSCLC_38242124__IMC__175_C3,5 | Lung | Primary cancer | 2,899 | Tumor/Malignant cell | 45.2% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__175_C3,6 | Lung | Primary cancer | 2,613 | Fibroblast | 36.1% | 0.81 | 0.51 |
| NSCLC_38242124__IMC__175_C3,7 | Lung | Primary cancer | 3,382 | Tumor/Malignant cell | 45.4% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__175_C3,8 | Lung | Primary cancer | 2,698 | Tumor/Malignant cell | 62.8% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__175_C3,9 | Lung | Primary cancer | 2,511 | Tumor/Malignant cell | 50.5% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__175_C4,1 | Lung | Primary cancer | 1,967 | Tumor/Malignant cell | 64.7% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_C4,10 | Lung | Primary cancer | 3,736 | Tumor/Malignant cell | 64.6% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__175_C4,11 | Lung | Primary cancer | 3,999 | Tumor/Malignant cell | 46.8% | 0.91 | 0.28 |
| NSCLC_38242124__IMC__175_C4,12 | Lung | Primary cancer | 5,572 | Fibroblast | 79.2% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__175_C4,13 | Lung | Primary cancer | 4,073 | Fibroblast | 77.5% | 0.97 | 0.09 |